These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38643415)

  • 21. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond.
    Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S
    J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury.
    Papa L; Ladde JG; O'Brien JF; Thundiyil JG; Tesar J; Leech S; Cassidy DD; Roa J; Hunter C; Miller S; Baker S; Parrish GA; Davison J; Van Dillen C; Ralls GA; Briscoe J; Falk JL; Weber K; Giordano PA
    JAMA Netw Open; 2022 Mar; 5(3):e221302. PubMed ID: 35285924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood biomarkers of mild traumatic brain injury: State of art.
    Sapin V; Gaulmin R; Aubin R; Walrand S; Coste A; Abbot M
    Neurochirurgie; 2021 May; 67(3):249-254. PubMed ID: 33482234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions.
    Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B
    Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
    Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
    J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Acute and Subacute Blood Biomarkers to Assist Diagnosis in CT-Negative Isolated Mild Traumatic Brain Injury.
    Reyes J; Spitz G; Major BP; O'Brien WT; Giesler LP; Bain JWP; Xie B; Rosenfeld JV; Law M; Ponsford JL; O'Brien TJ; Shultz SR; Willmott C; Mitra B; McDonald SJ
    Neurology; 2023 Nov; 101(20):e1992-e2004. PubMed ID: 37788938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of Blood Biomarkers of Traumatic Brain Injury.
    Rezaii PG; Grant GA; Zeineh MM; Richardson KJ; Coburn ML; Bet AM; Weber A; Jiang B; Li Y; Ubungen K; Routh G; Wheatcroft AM; Paulino AD; Hayes RL; Steinberg GK; Wintermark M
    J Neurotrauma; 2019 Aug; 36(16):2407-2416. PubMed ID: 30968744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury.
    Papa L; Brophy GM; Alvarez W; Hirschl R; Cress M; Weber K; Giordano P
    Sci Rep; 2023 Jul; 13(1):11833. PubMed ID: 37481589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
    Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
    Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?
    Rhine T; Babcock L; Zhang N; Leach J; Wade SL
    Brain Inj; 2016; 30(10):1231-8. PubMed ID: 27416022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 Minutes of Traumatic Brain Injury.
    Papa L; McKinley WI; Valadka AB; Newman ZC; Nordgren RK; Pramuka PE; Barbosa CE; Brito AMP; Loss LJ; Tinoco-Garcia L; Hinson HE; Schreiber MA; Rowell SE
    JAMA Netw Open; 2024 Sep; 7(9):e2431115. PubMed ID: 39230905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-Dependent Differences in Blood Levels of Glial Fibrillary Acidic Protein but Not Ubiquitin Carboxy-Terminal Hydrolase L1 in Children.
    Mannix R; Borglund E; Monashefsky A; Master C; Corwin D; Badawy M; Thomas DG; Reisner A
    Neurology; 2024 Aug; 103(3):e209651. PubMed ID: 38986044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of ubiquitin C terminal hydrolase and S100β with cognitive deficits in young adults with mild traumatic brain injury.
    Dey S; Gangadharan J; Deepika A; Kumar JK; Christopher R; Ramesh SS; Devi BI; Shukla DP
    Neurol India; 2017; 65(4):761-766. PubMed ID: 28681747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression levels of ubiquitin C-terminal hydrolase-L1 and serum glial fibrillary acidic protein and its clinical significance in patients with acute cerebral infarction].
    Hu C; Yang X; Mao D; Lou S; Dai Q; Chen J; Cheng X; Wang S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):284-290. PubMed ID: 28364101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.